Authors:
OLIVER DW
DORMEHL IC
VANDERSCHYF CJ
NEUMEYER JL
HUGO N
KEEVE R
ROSSOUW NT
MULLERGARTNER HW
CASTAGNOLI N
Citation: Dw. Oliver et al., EFFECT OF THE HALOPERIDOL TETRAHYDROPYRIDINE METABOLITE UOROPHENYL)-4-OXOBUTYL]-1,2,3,6-TETRAHYDROPYRIDINE ON DOPAMINE-RECEPTOR AND TRANSPORTER BINDING - A NONHUMAN PRIMATE I-123 IODOBENZAMIDE AND 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHIC STUDY, Arzneimittel-Forschung, 47(6), 1997, pp. 692-699
Authors:
VANDERSCHYF CJ
DORMEHL IC
OLIVER DW
HUGO N
KEEVE R
MULLERGARTNER HW
POND SM
CASTAGNOLI N
Citation: Cj. Vanderschyf et al., LONG-TERM TREATMENT WITH THE TETRAHYDROPYRIDINE ANALOG (HPTP) OF HALOPERIDOL INFLUENCES DOPAMINE LIGAND-BINDING IN BABOON BRAIN - AN [I-123] IODOBENZAMIDE (IBZM) SPECT STUDY, Molecular brain research, 43(1-2), 1996, pp. 251-258
Authors:
AVENT KM
USUKI E
EYLES DW
KEEVE R
VANDERSCHYF CJ
CASTAGNOLI N
POND SM
Citation: Km. Avent et al., HALOPERIDOL AND ITS TETRAHYDROPYRIDINE DERIVATIVE (HPTP) ARE METABOLIZED TO POTENTIALLY NEUROTOXIC PYRIDINIUM SPECIES IN THE BABOON, Life sciences, 59(17), 1996, pp. 1473-1482